Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Kidney Cancer treatment details. Chemotherapy. Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Survival: 11.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Emcyt
Country: United States
City/State/Province: Philadelphia, Pennsylvania
Hospital: Fox Chase Cancer Center
Journal: Link
Date: 11/2003

Patients: This Phase II trial involved 21 patients with metastatic renal cell carcinoma; 16 men and 5 women. Median age was 64 years. Eleven patients had undergone previous nephrectomy, seven had previous radiation therapy, and two had previous biologic therapy.

Treatment: The treatment consisted of two chemotherapy drugs, vinblastine (velban) and estramustine (emcyt).

Toxicity: Grade 3-4 toxicities included hematologic, emesis, fatigue, and neurotoxicity.

Results: Median survival was 49 weeks (11.3 months).

Correspondence: Naomi B. Haas, MD

E-mail to a Friend Email Physician More Information